Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

Dr Reddy's Laboratories shares outstanding for the quarter ending December 31, 2024 were 0.834B, a 0.05% increase year-over-year.

  • Dr Reddy's Laboratories 2025 shares outstanding were 0.834B, a 0.08% increase from 2024.
  • Dr Reddy's Laboratories 2024 shares outstanding were 0.834B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.832B, a 0.03% increase from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Dr Reddy's Laboratories Shares Outstanding 2010-2024 | RDY

  • Dr Reddy's Laboratories 2025 shares outstanding were 0.834B, a 0.08% increase from 2024.
  • Dr Reddy's Laboratories 2024 shares outstanding were 0.834B, a 0.19% increase from 2023.
  • Dr Reddy's Laboratories 2023 shares outstanding were 0.832B, a 0.03% increase from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M